Largest study of BRCA1 and BRCA2 carriers refines cancer risk estimates in Asian population
Can't see this email? View it online
   
  Radiology Radiology logo  
  The latest radiology news from News Medical  
 PET brain scans could reveal hidden inflammation in patients with multiple sclerosisPET brain scans could reveal hidden inflammation in patients with multiple sclerosis
 
A Brigham and Women’s Hospital study of 30 people found that, in patients with MS, advanced brain imaging could identify hidden inflammation not picked up on traditional MRIs
 
 
 Largest study of BRCA1 and BRCA2 carriers refines cancer risk estimates in Asian populationLargest study of BRCA1 and BRCA2 carriers refines cancer risk estimates in Asian population
 
A team of clinician-scientists and scientists from the University of Nottingham (Malaysia campus), National Cancer Centre Singapore (NCCS), Cancer Research Malaysia, Nanyang Technological University, Singapore (NTU Singapore), University of Malaya, University of Cambridge, A*STAR's Genome Institute of Singapore (GIS) and other institutions, have conducted the largest study done to date of BRCA1 and BRCA2 (BReast CAncer Gene 1 and 2) carriers in...
 
   New brain connectivity maps offer insights into human consciousnessNew brain connectivity maps offer insights into human consciousness
 
In a paper titled, "Multimodal MRI reveals brainstem connections that sustain wakefulness in human consciousness," published today in Science Translational Medicine, a group of researchers at Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, and Boston Children's Hospital, created a connectivity map of a brain network that they propose is critical to human consciousness.
 
   Progression of subtle CT abnormalities in smokers predicts acute respiratory diseaseProgression of subtle CT abnormalities in smokers predicts acute respiratory disease
 
Smokers who have small abnormalities on their CT scans that grow over time have a greater likelihood of experiencing acute respiratory disease events, according to a new study published today in Radiology, a journal of the Radiological Society of North America.
 
   Pivotal roundtable focuses on ultrasound training and certification for primary maternal health cliniciansPivotal roundtable focuses on ultrasound training and certification for primary maternal health clinicians
 
Inteleos is set to host a pivotal roundtable alongside a side event during the WHO World Health Assembly and the AI for Good Global Summit.
 
 Large language models could impact breast imaging reports classification
 
Large language models could impact breast imaging reports classificationUse of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international study published today in the journal Radiology, a journal of the Radiological Society of North America.
 
 
 New biomarker predicts immunotherapy response in gastrointestinal cancers
 
New biomarker predicts immunotherapy response in gastrointestinal cancersDespite significant progress in treating gastrointestinal (GI) cancers through surgical resection, chemotherapy, radiotherapy, and targeted therapy, the objective response rate (ORR) for immune checkpoint inhibitor (ICI) therapy remains low.
 
 
 Listening to mindfulness audio recordings eases side effects of radiation therapy
 
Listening to mindfulness audio recordings eases side effects of radiation therapyMen with prostate cancer who are treated with radiation therapy experience significant side effects such as fatigue, sleep problems, anxiety and depressive symptoms. But listening to mindfulness audio recordings significantly eased those symptoms, a new Northwestern Medicine study has found.
 
 
 Hanson Wade - 3rd Targeted Radiopharmaceuticals Summit
 
Hanson Wade - 3rd Targeted Radiopharmaceuticals SummitFollowing huge billion-dollar deals from the likes of Novartis, Eli Lilly, BMS hot off the press, and AstraZeneca and continued positive clinical momentum off the back off the (expected to be blockbuster drug) Pluvicto approval, we are entering the radiopharmaceutical renaissance.